Log In
Print this Print this

Zoptrex, zoptarelin doxorubicin (formerly AEZS-108, AN-152, ZEN-008)

  Manage Alerts
Collapse Summary General Information
Company Aeterna Zentaris Inc.
DescriptionDoxorubicin chemotherapeutic conjugated to luteinizing hormone-releasing hormone (LHRH) receptor agonist
Molecular Target Luteinizing hormone-releasing hormone (LHRH)
Mechanism of ActionGnRH/LHRH receptor agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today